METHOD FOR TREATING PATIENTS WITH HELICOBACTER PYLORI-NEGATIVE EROSIVE ULCEROUS GASTRIC AND DUODENAL LESIONS IN SETTING OF CHRONIC OBSTRUCTIVE LUNG DISEASE

摘要

A method for treating the patients with Helicobacter pylori-negative erosive ulcerous gastric and duodenal lesions in the setting of the chronic obstructive lung disease provides for the basic therapy and the use of Normodipin at a daily dose of 5 mg for 4 weeks.